ADAPTIMMUNE THERAPEUTICS PLC (ADAPY) Total liabilities 2016–2024
ADAPTIMMUNE THERAPEUTICS PLC (ADAPY) total liabilities at each fiscal year-end, per SEC filings.
$234.1MFY2024 · since FY2016: $68.4M → $234.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $234.1M | -3.7% |
| FY2023 | $243.1M | -1.6% |
| FY2022 | $247.0M | -6.3% |
| FY2021 | $263.6M | +139.8% |
| FY2020 | $109.9M | +89.8% |
| FY2019 | $57.9M | +94.0% |
| FY2018 | $29.9M | -61.8% |
| FY2017 | $78.2M | +14.3% |
| FY2016 | $68.4M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice